EyePoint Pharmaceuticals
EYPT
EYPT
84 hedge funds and large institutions have $236M invested in EyePoint Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.73% less ownership
Funds ownership: 89.43% → 88.7% (-0.73%)
36% less capital invested
Capital invested by funds: $368M → $236M (-$132M)
Holders
84
Holding in Top 10
1
Calls
$1.35M
Puts
$157K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$1.47M | |
| 3 | +$1.03M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$964K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$632K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$3.38M | |
| 3 | -$1.59M | |
| 4 |
D.E. Shaw & Co
New York
|
-$391K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$274K |